デフォルト表紙
市場調査レポート
商品コード
1481448

スペクトルCTの世界市場規模、シェア、成長分析、製品別、用途別-産業予測、2024年~2031年

Global Spectral Computed Tomography Market Size, Share, Growth Analysis, By Product(Spiral CT, Electron Beam Tomography), By Application(Oncology, Neurology) - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 219 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
スペクトルCTの世界市場規模、シェア、成長分析、製品別、用途別-産業予測、2024年~2031年
出版日: 2024年05月15日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

スペクトルCTの世界市場規模は2022年に70億3,000万米ドルと評価され、2023年の74億9,000万米ドルから2031年には123億9,000万米ドルに成長し、予測期間(2024年~2031年)のCAGRは6.5%で成長する見通しです。

世界のスペクトルCT(コンピュータ断層撮影)市場は、イメージング技術の進歩や医療診断におけるアプリケーションの増加によって大きな成長を遂げています。デュアルエナジーCTとしても知られるスペクトルCTは、正確な疾患検出と特徴付けに不可欠な詳細画像と物質鑑別を提供することで診断精度を向上させる。がんや心血管疾患などの慢性疾患の有病率の上昇は、高度な診断ツールに対する需要を煽り、市場拡大を後押ししています。加えて、高齢化社会と早期疾病診断に対する意識の高まりも市場拡大に寄与しています。人工知能や機械学習の統合を含む技術革新は、スペクトルCTの機能をさらに拡張し、現代のヘルスケアに不可欠なものとなっています。市場開拓企業は、市場での存在感を高め、医療従事者の進化するニーズに対応するため、製品開発や戦略的提携に注力しています。しかし、スペクトルCTシステムの高価格や新興国におけるアクセス制限などが市場成長の課題となっています。このようなハードルにもかかわらず、スペクトルCT市場は、継続的な技術の進歩と世界の臨床現場での採用の増加により、力強い成長を遂げる態勢が整っています。

目次

エグゼクティブサマリー

  • 市場概要
  • 運命の輪

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の危機と限界

親市場の分析

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題

主な市場の考察

  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料の分析
  • イノベーションマトリクス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • 規制情勢
  • ポーターの分析
  • 将来の混乱についての特別な考察

スペクトルCTの世界市場:製品別

  • 市場概要
  • スパイラルCT
  • 電子線トモグラフィー
  • マルチスライスCT
  • 陽電子放出断層撮影(PET)と単一光子放出コンピュータ断層撮影

スペクトルCTの世界市場:用途別

  • 市場概要
  • 腫瘍学
  • 神経学
  • 心臓病学
  • 血管およびその他

スペクトルCTの世界市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他のラテンアメリカ
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他の中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Toshiba Medical Systems Corporation
  • Hitachi Medical Corporation
  • Shimadzu Corporation
  • Carestream Health
  • Samsung Medison
  • Hologic, Inc.
  • Fujifilm Medical Systems
  • Esaote SpA
  • Agfa-Gevaert Group
  • Mindray Medical International Limited
  • Planmed
  • CurveBeam LLC
  • Medtronic plc
  • Konica Minolta, Inc.
  • Varian Medical Systems
  • Analogic Corporation
  • NeuroLogica Corporation
  • Xoran Technologies, LLC
  • Cubresa Inc.
目次
Product Code: SQMIG35A2794

Global Spectral Computed Tomography Market size was valued at USD 7.03 billion in 2022 and is poised to grow from USD 7.49 billion in 2023 to USD 12.39 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The global spectral computed tomography (CT) market is experiencing significant growth driven by advancements in imaging technology and increasing applications in medical diagnostics. Spectral CT, also known as dual-energy CT, enhances diagnostic accuracy by providing detailed images and material differentiation, crucial for precise disease detection and characterization. The rising prevalence of chronic diseases such as cancer and cardiovascular conditions fuels the demand for advanced diagnostic tools, propelling market expansion. Additionally, the aging population and growing awareness of early disease diagnosis contribute to market growth. Technological innovations, including the integration of artificial intelligence and machine learning, further augment the capabilities of spectral CT, making it indispensable in modern healthcare. Market players are focusing on product development and strategic collaborations to enhance their market presence and address the evolving needs of healthcare professionals. However, the high cost of spectral CT systems and limited access in emerging economies pose challenges to market growth. Despite these hurdles, the spectral CT market is poised for robust growth, driven by continuous technological advancements and increasing adoption in clinical practices worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spectral Computed Tomography Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Spectral Computed Tomography Market Segmental Analysis

The global spectral computed tomography market is segmented on the basis of product, filament, application and region. By product, the segmented into spiral CT, electron beam tomography, multi-slice computed tomography, positron emission tomography (Pet) and single-photon emission computed tomography. By application, the market is segmented into oncology, neurology, cardiology, vascular and others. By end use, the market is segmented into hospitals, diagnostics imaging center and ambulatory imaging center and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Spectral Computed Tomography Market

The promise of improved diagnostic accuracy is propelling the market for spectral computed tomography (CT) expansion. By collecting data at various energy levels, spectral CT technology surpasses traditional CT scanning and enables more thorough analyses of material characteristics and tissue composition. This development makes it possible for medical practitioners to get thorough understanding of the fundamental characteristics of tissues, which improves the identification and description of a range of illnesses. Diagnostic accuracy is improved when distinct materials can be distinguished from one another using their spectral fingerprints, especially in complicated situations where conventional CT imaging may not be sufficient. Spectral CT helps with early and accurate diagnosis by offering a more sophisticated picture of tissue composition. This improves patient outcomes and opens the door for more specialized and efficient medical therapies.

Restraints in the Global Spectral Computed Tomography Market

There may be a dearth of clinical data to demonstrate spectral CT's superiority over conventional CT in some situations, despite its intriguing potential to provide improved diagnostic information. The paucity of solid clinical evidence indicating distinct advantages in particular medical contexts may cause medical professionals to be reluctant to completely adopt spectral CT.

Market Trends of the Global Spectral Computed Tomography Market

Unexpected developments have occurred in the spectral CT market, primarily in the area of radiation dosage reduction. This development is consistent with the growing significance of radiation exposure reduction and patient safety during medical imaging operations. New developments in spectral CT technology include dual-energy imaging, which significantly reduces the radiation dose needed for scans while improving tissue characterisation and visualization. A significant breakthrough in diagnostic imaging, spectral CT uses distinct energy spectra to improve imaging techniques to get more information with lower radiation dose. This is especially useful for groups that are more vulnerable or for people who require repeated scans.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Spectral Computed Tomography Market by Product

  • Market Overview
  • Spiral CT
  • Electron Beam Tomography
  • Multi-slice Computed Tomography
  • Positron Emission Tomography (Pet) and Single-photon Emission Computed Tomography

Global Spectral Computed Tomography Market by Application

  • Market Overview
  • Oncology
  • Neurology
  • Cardiology
  • Vascular and Others

Global Spectral Computed Tomography Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Siemens Healthineers
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Toshiba Medical Systems Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hitachi Medical Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carestream Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Samsung Medison
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Esaote SpA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agfa-Gevaert Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mindray Medical International Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Planmed
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CurveBeam LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Konica Minolta, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Varian Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Analogic Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuroLogica Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xoran Technologies, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cubresa Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments